SeenewsSeenews
Search
Seenews
AlertsSeenewsSeenews
Searchclose
TOPICS
arrow
COUNTRIES
arrow
INDUSTRY
arrow
Economy
arrow
Browse Economy
Mix and match your focus countries with our advanced search
Investments
arrow
Browse Investments
Mix and match your focus countries with our advanced search
Deals
arrow
Browse Deals
Mix and match your focus countries with our advanced search
Tech
arrow
Browse Tech
Mix and match your focus countries with our advanced search
Green
arrow
Browse Green
Mix and match your focus countries with our advanced search
0/5
You have 5 free articles left this month
You have 0/5 free articles
Sign up to get 5 more free articles this month
SIGN UP
arrow
LOGIN
arrow

N. Macedonia's Replek posts 21% rise in Q1 net profit

Apr 30, 2024, 12:05:01 PMArticle by Dragana Petrushevska
share
April 30 (SeeNews) - North Macedonia-based drug maker Replek [MSE:REPL] said on Tuesday that its consolidated net profit rose 21% year-on-year to 22.9 million denars ($398,368/371,899 euro) in the first quarter of 2024.

N. Macedonia's Replek posts 21% rise in Q1 net profit

Replek's operating revenue rose 25% on the year to 395.2 million denars in January-March, whereas operating costs were 33% higher at 383.5 million denars, the company said in an interim financial statement filed with the Skopje bourse.

Sales revenues from the domestic market gained 39% on an annual comparison basis, reaching 75.7 million denars in the first quarter. Sales revenues from abroad increased 23% to 312.2 million denars.

Replek's shares last traded at an average price of 109,000 denars on the Macedonian Stock Exchange (MSE) on April 26, according to the latest available bourse data.

(1 euro = 61.58 denars)

Your complete guide to the emerging economies of Southeast Europe. From latest news to bespoke research – the big picture at the tip of your fingers.